Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Pozycja w akcjach #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Cena akcji
$4.51
Kapitalizacja rynkowa
$540.82M
Zmiana (1 dzień)
-2.42%
Zmiana (1 rok)
-43.50%
Kraj
CN
Handel Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Kategoria

Historia ceny akcji dla Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Najwyższa cena zamknięcia: $4.90 dnia 2026-08-01

Najniższa cena zamknięcia: $2.62 dnia 2017-01-01
Historia cen akcji firmy Nanjing Hicin Pharmaceutical Co., Ltd. od 2017 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -8.43%
2025 143.40%
2024 -11.77%
2023 -29.60%
2022 69.07%
2021 -18.98%
2020 -10.68%
2019 -0.37%
2018 22.24%
2017 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$165.71 30.94%
DE
$37.61 25.11%
JP
$219.53 25.89%
CH
$21.26 17.56%
IN